Historical Trial Data
NEALS maintains and makes available the de-indentified data from our trials, when possible. Currently NEALS has 6 ALS trial databases available for researchers to mine:
- A Randomized, Placebo-Controlled Trial of Topiramate in Amyotrophic Lateral Sclerosis
- Trial of Celecoxib in Amyotrophic Lateral Sclerosis
- A Clinical Trial of Creatine in ALS
- Tolerance of high-dose coenzyme Q10 in ALS
- Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis
- A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS
To request access to NEALS data please fill out a Data Request Form and submit to: Tara Lincoln, NEALS Director of Operations, at email@example.com
Download the Data Request Form.
NEALS Data Sharing Policy
Below is an overview of the NEALS Data Sharing Policy.
Type of Data to be Shared: With permission from the sponsor, de-identified data from NEALS clinical studies will be made available to all members of the Consortium. This includes data generated during clinical trials or other types of clinical research studies that involve human research subjects.
As part of the NEALS mission to move research from the laboratory into clinical trials, we encourage members to share non-NEALS data (generated with funding outside of NEALS), to the extent possible under outside funding, internal institutional constraints and external collaborator policies.
Protection of Human Subjects and Privacy Issues: NEALS Consortium is in agreement with the NIH and their guidelines for protecting human subjects and their privacy. We agree to abide by the intent of the policy as it is stated, “The rights and privacy of human subjects who participate in NIH-sponsored research must be protected at all times. It is the responsibility of the investigators, their Institutional Review Board (IRB), and their institution to protect the rights of subjects and the confidentiality of the data. Prior to sharing, data should be redacted to strip all identifiers, and effective strategies should be adopted to minimize risks of unauthorized disclosure of personal identifiers.”
Before approving a data request, NEALS will confirm that the data from individual trials and/or studies that are shared by members, have been de-identified and will not reveal individual subject identifying information (names) and adhere to HIPAA Privacy Rule 5.
NEALS members will abide by the Institutional Review Board (IRB) regulations and requirements of their individual IRB as it pertains to data sharing.